Suspension of trading

Valuation BioSenic SA

Stocks

Market Closed - Euronext Bruxelles 11:55:00 2026-08-21 EDT			5-day change	1st Jan Change
0.002000 ^EUR	0.00%		0.00%	-13.04%

25-10-27	BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-10-02	BioSenic S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024
Market Cap ¹	2.998	9.987	1.879
Change	-	233.11%	-81.19%
Enterprise Value (EV) ¹	24.94	38.03	29.21
Change	-	52.47%	-23.17%
P/E	-5.65x	-0.29x	-0.28x
PBR	6.54x	-0.44x	-0.07x
PEG	-	-0x	0x
Capitalization / Revenue	10.1x	29.7x	18.4x
EV / Revenue	84.3x	113x	286x
EV / EBITDA	-10.8x	-5.43x	-5.94x
EV / EBIT	-10.8x	-5.4x	-5.61x
EV / FCF	-13.3x	-17x	-7.16x
FCF Yield	-7.49%	-5.89%	-14%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-0.017	-0.2102	-0.0206
Distribution rate	-	-	-
Net sales ¹	0.296	0.336	0.102
EBITDA ¹	-2.299	-6.998	-4.915
EBIT ¹	-2.318	-7.039	-5.206
Net income ¹	-2.041	-28.78	-4.768
Net Debt ¹	21.94	28.04	27.34
Reference price ²	0.096000	0.061200	0.005800
Nbr of stocks (in thousands)	31,229	163,181	323,932
Announcement Date	7/12/24	7/12/24	10/3/25

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOSENIC SA	-	-	-	-	1.52M
ELI LILLY AND COMPANY	35.74x	12.95x	26.26x	0.55%	1,119B
JOHNSON & JOHNSON	30.06x	-	-	1.99%	651B
ABBVIE INC.	33.82x	7.82x	16.26x	2.59%	468B
ROCHE HOLDING AG	20.93x	4.96x	12.28x	2.66%	374B
NOVARTIS AG	22.59x	5.81x	14.4x	2.75%	302B
ASTRAZENECA PLC	21.37x	4.4x	12.49x	1.99%	259B
AMGEN INC.	27.79x	7.17x	12.73x	2.3%	238B
NOVO NORDISK A/S	13.71x	4.87x	10.23x	3.75%	208B
GILEAD SCIENCES, INC.	-44.65x	6.45x	25.18x	2.26%	181B
Average	17.93x	6.80x	16.23x	2.31%	379.99B
Weighted average by Cap.	25.51x	8.51x	18.70x	1.89%